The Oslo Medicines Initiative:
a new social contract with pharma

Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe.

The Oslo Medicines Initiative: Better access to effective, novel, high-priced medicines – a new vision for collaboration between the public and private sectors is a new initiative of the WHO Regional Office for Europe, developed together with the Norwegian Ministry of Health and Care Services and the Norwegian Medicines Agency.

The Initiative aims to provide a neutral platform for the public and private sectors to jointly outline a vision for equitable and sustainable access to effective, innovative and affordable medicines.

Join us to discuss why a new social contract is needed to build an environment of mutual trust and cooperation between the pharmaceutical industry, governments and patients.